Withum
JUNE 6, 2022
The taxpayer in PLR 202221006 (March 3, 2022) is a pharmaceutical distributor that engages in the retail sale of a limited number of drugs. Conversely, if the business is not a QTB, then the shareholder will owe federal income tax of roughly $2,380,000 ($10 million times 23.8%).
Withum
DECEMBER 23, 2023
More recently, tax writers were meeting on a regular basis and the news reported on a rough outline of a plan, but that came to nothing. So now Congressional leaders have departed for winter recess and will return to a full plate of financing the government when they return. So what can we expect in the New Year?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cherry Bekaert
JULY 20, 2023
The proportional amortization method results in the cost of the investment being amortized in proportion to the income tax credits and other tax benefits received, with the amortization being presented net in the income statement as a component of income tax expense (benefit).
CPA Practice
FEBRUARY 8, 2023
He has extensive experience in tax across a range of industries including construction, real estate, hospitality, consumer products, technology, pharmaceutical, manufacturing, aerospace and defense, e-business, transportation, finance and agriculture.
Going Concern
JULY 14, 2023
Prior to joining DLA, John served as a Partner with two National professional services firms, where he was the subject matter expert on business combinations, impairment analysis, income tax accounting, stock compensation, revenue recognition, and going concern analysis.
KROST
NOVEMBER 24, 2020
These two incentives can provide significant tax relief in 2020 if financed and placed in service by midnight, December 31, 2020. The Research and Development tax credit is one of the most lucrative incentives under current U.S. tax law because it is a dollar-for-dollar reduction in a tax liability.
Expert insights. Personalized for you.
126 
Let's personalize your content